{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:54:16Z","timestamp":1791982456181,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-022-00902-5","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T16:03:30Z","timestamp":1656950610000},"page":"791-805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":251,"title":["Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine"],"prefix":"10.1038","volume":"6","author":[{"given":"Zhenzhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen D.","family":"Popowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4645-5786","authenticated-orcid":false,"given":"Dashuai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-363X","authenticated-orcid":false,"given":"Blanca L\u00f3pez","family":"de Juan Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6364-7627","authenticated-orcid":false,"given":"Halle","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"De Naeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Todd","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-6256","authenticated-orcid":false,"given":"Phuong-Uyen C.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9751-0864","authenticated-orcid":false,"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-6893","authenticated-orcid":false,"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"902_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. Lancet 395, 470\u2013473 (2020).","journal-title":"Lancet"},{"key":"902_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-j Guan","year":"2020","unstructured":"Guan, W.-j et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"902_CR3","first-page":"22","volume":"39","author":"K Sharma","year":"2021","unstructured":"Sharma, K. et al. Vaccines for COVID-19: where do we stand in 2021? Paediatr. Respir. Rev. 39, 22\u201331 (2021).","journal-title":"Paediatr. Respir. Rev."},{"key":"902_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/vaccines9080881","volume":"9","author":"RG King","year":"2021","unstructured":"King, R. G. et al. Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 and fully protects mice from lethal challenge. Vaccines 9, 881 (2021).","journal-title":"Vaccines"},{"key":"902_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","volume":"183","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183, 169\u2013184 (2020).","journal-title":"Cell"},{"key":"902_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00292-w","volume":"6","author":"NC Kyriakidis","year":"2021","unstructured":"Kyriakidis, N. C., Lopez-Cortes, A., Gonzalez, E. V., Grimaldos, A. B. & Prado, E. O. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. NPJ Vaccines 6, 28 (2021).","journal-title":"NPJ Vaccines"},{"key":"902_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292 (2020).","journal-title":"Cell"},{"key":"902_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya, A. E. et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536\u2013544 (2020).","journal-title":"Nat. Microbiol."},{"key":"902_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil, V. et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181, 905\u2013913 (2020).","journal-title":"Cell"},{"key":"902_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"902_CR11","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00018-020-03580-1","volume":"78","author":"I Mercurio","year":"2020","unstructured":"Mercurio, I., Tragni, V., Busto, F., De Grassi, A. & Pierri, C. L. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies. Cell. Mol. Life Sci. 78, 1501\u20131522 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"902_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"902_CR13","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1080\/21645515.2020.1740560","volume":"16","author":"W-H Chen","year":"2020","unstructured":"Chen, W.-H., Hotez, P. J. & Bottazzi, M. E. Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19. Hum. Vaccines Immunother. 16, 1239\u20131242 (2020).","journal-title":"Hum. Vaccines Immunother."},{"key":"902_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","volume":"17","author":"W Tai","year":"2020","unstructured":"Tai, W. et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 17, 613\u2013620 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"902_CR15","doi-asserted-by":"publisher","first-page":"104820","DOI":"10.1016\/j.antiviral.2020.104820","volume":"179","author":"W Tai","year":"2020","unstructured":"Tai, W., Zhang, X., He, Y., Jiang, S. & Du, L. Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2. Antiviral Res. 179, 104820 (2020).","journal-title":"Antiviral Res."},{"key":"902_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.biomaterials.2017.09.020","volume":"147","author":"A Parodi","year":"2017","unstructured":"Parodi, A. et al. Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery. Biomaterials 147, 155\u2013168 (2017).","journal-title":"Biomaterials"},{"key":"902_CR17","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00018-019-03035-2","volume":"76","author":"H Kahroba","year":"2019","unstructured":"Kahroba, H., Hejazi, M. S. & Samadi, N. Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer. Cell. Mol. Life Sci. 76, 1747\u20131758 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"902_CR18","doi-asserted-by":"publisher","first-page":"1785161","DOI":"10.1080\/20013078.2020.1785161","volume":"9","author":"K Popowski","year":"2020","unstructured":"Popowski, K. et al. Exosome therapeutics for lung regenerative medicine. J. Extracell. Vesicles 9, 1785161 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"902_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.copbio.2019.01.005","volume":"60","author":"C-Y Kao","year":"2019","unstructured":"Kao, C.-Y. & Papoutsakis, E. T. Extracellular vesicles: exosomes, microparticles, their parts, and their targets to enable their biomanufacturing and clinical applications. Curr. Opin. Biotechnol. 60, 89\u201398 (2019).","journal-title":"Curr. Opin. Biotechnol."},{"key":"902_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/pharmaceutics10040218","volume":"10","author":"SG Antimisiaris","year":"2018","unstructured":"Antimisiaris, S. G., Mourtas, S. & Marazioti, A. Exosomes and exosome-inspired vesicles for targeted drug delivery. Pharmaceutics 10, 218 (2018).","journal-title":"Pharmaceutics"},{"key":"902_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","volume":"21","author":"M Simons","year":"2009","unstructured":"Simons, M. & Raposo, G. Exosomes \u2013 vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21, 575\u2013581 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"902_CR22","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.5966\/sctm.2015-0062","volume":"4","author":"E Henry","year":"2015","unstructured":"Henry, E. et al. Adult lung spheroid cells contain progenitor cells and mediate regeneration in rodents with bleomycin-induced pulmonary fibrosis. Stem Cells Transl. Med. 4, 1265\u20131274 (2015).","journal-title":"Stem Cells Transl. Med."},{"key":"902_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12931-017-0611-0","volume":"18","author":"P-UC Dinh","year":"2017","unstructured":"Dinh, P.-U. C. et al. Derivation of therapeutic lung spheroid cells from minimally invasive transbronchial pulmonary biopsies. Respir. Res. 18, 132 (2017).","journal-title":"Respir. Res."},{"key":"902_CR24","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/sctm.16-0374","volume":"6","author":"J Cores","year":"2017","unstructured":"Cores, J. et al. Safety and efficacy of allogeneic lung spheroid cells in a mismatched rat model of pulmonary fibrosis. Stem Cells Transl. Med. 6, 1905\u20131916 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"902_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/sctm.19-0167","volume":"9","author":"J Cores","year":"2020","unstructured":"Cores, J. et al. A pre-investigational new drug study of lung spheroid cell therapy for treating pulmonary fibrosis. Stem Cells Transl. Med. 9, 786\u2013798 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"902_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14344-7","volume":"11","author":"P-UC Dinh","year":"2020","unstructured":"Dinh, P.-U. C. et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat. Commun. 11, 1064 (2020).","journal-title":"Nat. Commun."},{"key":"902_CR27","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","volume":"383","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. N. Engl. J. Med. 383, 1544\u20131555 (2020).","journal-title":"N. Engl. J. Med."},{"key":"902_CR28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin, U. et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature 586, 594\u2013599 (2020).","journal-title":"Nature"},{"key":"902_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","volume":"586","author":"MJ Mulligan","year":"2020","unstructured":"Mulligan, M. J. et al. Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589\u2013593 (2020).","journal-title":"Nature"},{"key":"902_CR30","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","volume":"182","author":"N-N Zhang","year":"2020","unstructured":"Zhang, N.-N. et al. A thermostable mRNA vaccine against COVID-19. Cell 182, 1271\u20131283 (2020).","journal-title":"Cell"},{"key":"902_CR31","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.2147\/IJN.S182384","volume":"13","author":"Z Naseri","year":"2018","unstructured":"Naseri, Z., Oskuee, R. K., Jaafari, M. R. & Forouzandeh Moghadam, M. Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo. Int. J. Nanomed. 13, 7727\u20137747 (2018).","journal-title":"Int. J. Nanomed."},{"key":"902_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02014-6","volume":"7","author":"I Nakase","year":"2017","unstructured":"Nakase, I. et al. Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery. Sci. Rep. 7, 1991 (2017).","journal-title":"Sci. Rep."},{"key":"902_CR33","doi-asserted-by":"publisher","first-page":"12193","DOI":"10.1021\/acsnano.8b05892","volume":"12","author":"Z Li","year":"2018","unstructured":"Li, Z. et al. Pretargeting and bioorthogonal click chemistry-mediated endogenous stem cell homing for heart repair. ACS Nano 12, 12193\u201312200 (2018).","journal-title":"ACS Nano"},{"key":"902_CR34","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1021\/acs.nanolett.8b04970","volume":"19","author":"D Shen","year":"2019","unstructured":"Shen, D. et al. Antibody-armed platelets for the regenerative targeting of endogenous stem cells. Nano Lett. 19, 1883\u20131891 (2019).","journal-title":"Nano Lett."},{"key":"902_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2183\/pjab.91.423","volume":"91","author":"H Kiyono","year":"2015","unstructured":"Kiyono, H. & Azegami, T. The mucosal immune system: from dentistry to vaccine development. Proc. Jpn. Acad. B 91, 423\u2013439 (2015).","journal-title":"Proc. Jpn. Acad. B"},{"key":"902_CR36","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","volume":"53","author":"D Laczko","year":"2020","unstructured":"Laczko, D. et al. A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice. Immunity 53, 724\u2013732 (2020).","journal-title":"Immunity"},{"key":"902_CR37","doi-asserted-by":"publisher","first-page":"eaan6205","DOI":"10.1126\/scitranslmed.aan6205","volume":"10","author":"M Miragoli","year":"2018","unstructured":"Miragoli, M. et al. Inhalation of peptide-loaded nanoparticles improves heart failure. Sci. Transl. Med. 10, eaan6205 (2018).","journal-title":"Sci. Transl. Med."},{"key":"902_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3251","volume":"12","author":"N Lycke","year":"2012","unstructured":"Lycke, N. Recent progress in mucosal vaccine development: potential and limitations. Nat. Rev. Immunol. 12, 592\u2013605 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"902_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","volume":"583","author":"SF Sia","year":"2020","unstructured":"Sia, S. F. et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583, 834\u2013838 (2020).","journal-title":"Nature"},{"key":"902_CR40","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/s41591-020-1070-6","volume":"26","author":"LH Tostanoski","year":"2020","unstructured":"Tostanoski, L. H. et al. Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. Nat. Med. 26, 1694\u20131700 (2020).","journal-title":"Nat. Med."},{"key":"902_CR41","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai, M. et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl Acad. Sci. USA 117, 16587\u201316595 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"902_CR42","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1126\/science.abe2402","volume":"370","author":"A Baum","year":"2020","unstructured":"Baum, A. et al. REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science 370, 1110\u20131115 (2020).","journal-title":"Science"},{"key":"902_CR43","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1126\/science.abe8499","volume":"370","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J. et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science 370, 1464\u20131468 (2020).","journal-title":"Science"},{"key":"902_CR44","doi-asserted-by":"publisher","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci. Transl. Med. 13, eabf1555 (2021).","journal-title":"Sci. Transl. Med."},{"key":"902_CR45","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1021\/acs.nanolett.0c02278","volume":"20","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Cellular nanosponges inhibit SARS-CoV-2 infectivity. Nano Lett. 20, 5570\u20135574 (2020).","journal-title":"Nano Lett."},{"key":"902_CR46","doi-asserted-by":"publisher","first-page":"27141","DOI":"10.1073\/pnas.2014352117","volume":"117","author":"L Rao","year":"2020","unstructured":"Rao, L. et al. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc. Natl Acad. Sci. USA 117, 27141\u201327147 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"902_CR47","doi-asserted-by":"publisher","first-page":"2004452","DOI":"10.1002\/adma.202004452","volume":"32","author":"C Zeng","year":"2020","unstructured":"Zeng, C. et al. Leveraging mRNA sequences and nanoparticles to deliver SARS-CoV-2 antigens in vivo. Adv. Mater. 32, 2004452 (2020).","journal-title":"Adv. Mater."},{"key":"902_CR48","doi-asserted-by":"publisher","first-page":"12370","DOI":"10.1021\/acsnano.0c06109","volume":"14","author":"X Zhou","year":"2020","unstructured":"Zhou, X. et al. Engineering antiviral vaccines. ACS Nano 14, 12370\u201312389 (2020).","journal-title":"ACS Nano"},{"key":"902_CR49","doi-asserted-by":"publisher","first-page":"eabh0755","DOI":"10.1126\/scitranslmed.abh0755","volume":"13","author":"NV Doremalen","year":"2021","unstructured":"Doremalen, N. V. et al. Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci. Transl. Med. 13, eabh0755 (2021).","journal-title":"Sci. Transl. Med."},{"key":"902_CR50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.abg9857","volume":"373","author":"FE Lund","year":"2021","unstructured":"Lund, F. E. & Randall, T. D. VIEWPOINT: COVID-19 scent of a vaccine. Science 373, 397 (2021).","journal-title":"Science"},{"key":"902_CR51","doi-asserted-by":"publisher","first-page":"100230","DOI":"10.1016\/j.xcrm.2021.100230","volume":"2","author":"AO Hassan","year":"2021","unstructured":"Hassan, A. O. et al. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques. Cell Rep. Med. 2, 100230 (2021).","journal-title":"Cell Rep. Med."},{"key":"902_CR52","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","volume":"21","author":"S Wu","year":"2021","unstructured":"Wu, S. et al. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect. Dis. 21, 1654\u20131664 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"902_CR53","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1021\/cr8004668","volume":"109","author":"LS Wong","year":"2009","unstructured":"Wong, L. S., Khan, F. & Micklefield, J. Selective covalent protein immobilization: strategies and applications. Chem. Rev. 109, 4025\u20134053 (2009).","journal-title":"Chem. Rev."},{"key":"902_CR54","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.mattod.2017.06.003","volume":"20","author":"K Dong","year":"2017","unstructured":"Dong, K. et al. Pathogen-mimicking nanocomplexes: self-stimulating oxidative stress in tumor microenvironment for chemo-immunotherapy. Mater. Today 20, 346\u2013353 (2017).","journal-title":"Mater. Today"},{"key":"902_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-4939-2550-6_15","volume":"1295","author":"DW Greening","year":"2015","unstructured":"Greening, D. W., Xu, R., Ji, H., Tauro, B. J. & Simpson, R. J. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol. Biol. 1295, 179\u2013209 (2015).","journal-title":"Methods Mol. Biol."},{"key":"902_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep36162","volume":"6","author":"S Bosch","year":"2016","unstructured":"Bosch, S. et al. Trehalose prevents aggregation of exosomes and cryodamage. Sci. Rep. 6, 36162 (2016).","journal-title":"Sci. Rep."},{"key":"902_CR57","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.colsurfb.2005.07.005","volume":"45","author":"A Saxena","year":"2005","unstructured":"Saxena, A., Sachin, K., Bohidar, H. B. & Verma, A. K. Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nano-particles. Colloids Surf. B 45, 42\u201348 (2005).","journal-title":"Colloids Surf. B"},{"key":"902_CR58","first-page":"129","volume":"2","author":"S Bajaj","year":"2012","unstructured":"Bajaj, S., Singla, D. & Sakhuja, N. Stability testing of pharmaceutical products. J. Appl. Pharm. Sci. 2, 129\u2013138 (2012).","journal-title":"J. Appl. Pharm. Sci."},{"key":"902_CR59","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41565-021-00923-2","volume":"16","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19. Nat. Nanotechnol. 16, 942\u2013951 (2021).","journal-title":"Nat. Nanotechnol."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00902-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00902-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00902-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:26:34Z","timestamp":1669299994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00902-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["902"],"URL":"https:\/\/doi.org\/10.1038\/s41551-022-00902-5","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.C. is a co-founder and equity holder of Xsome Biotech Inc. Xsome Biotech Inc. is a licensee of the intellectual property covering exosome delivery technologies and antiviral therapies from North Carolina State University. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}